SCHEMBL3430783

SCHEMBL3430783

CC(C)c1cccc(C(C)C)c1NC(=O)N(c1ccccc1)C(SCc1ccccc1)C1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.45
UBE2M P61081 1/20 0.43
DCUN1D1 Q96GG9 1/20 0.43
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
SOAT2 O75908 1/20 0.40
SOAT1 P35610 1/20 0.40
NMBR P28336 2/20 0.39
GRPR P30550 1/20 0.38
EPHX1 P07099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3404762 0.78 NMBR (0.49) SMN1; SMN2SOAT2SOAT1NMBR
SCHEMBL3409925 0.75 KMT2A (0.36) SMN1; SMN2UBE2MDCUN1D1LMNAKMT2A
SCHEMBL6803628 0.70 UBE2M (0.47) SMN1; SMN2UBE2MDCUN1D1LMNAKMT2A
SCHEMBL9273516 0.69 UBE2M (0.65) UBE2MDCUN1D1
SCHEMBL9273683 0.69 UBE2M (0.65) UBE2MDCUN1D1
SCHEMBL9273510 0.69 UBE2M (0.65) UBE2MDCUN1D1
SCHEMBL855625 0.69 SOAT2 (0.52) SMN1; SMN2UBE2MDCUN1D1LMNAKMT2A
SCHEMBL9275119 0.69 UBE2M (0.52) UBE2MDCUN1D1LMNAKMT2ASOAT2
SCHEMBL9275114 0.69 UBE2M (0.52) UBE2MDCUN1D1LMNAKMT2ASOAT2
SCHEMBL6802084 0.68 UBE2M (0.45) UBE2MDCUN1D1KMT2ASOAT2SOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2200979-A1 NOVEL DERIVATIVES OF PHENYLUREAS, INHIBITORS OF THE SOAT-1 ENZYME, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM Galderma Research & Development (FR) 2010-06-30 EP disclosed
WO-2009030752-A1 NOVEL DERIVATIVES OF PHENYLUREAS, INHIBITORS OF THE SOAT-1 ENZYME, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GALDERMA RESEARCH & DEVELOPMENT (FR) 2009-03-12 WO disclosed